Severe poisoning after self-reported use of 2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine, a novel substituted amphetamine: a case series - 05/12/15
Doi : 10.1016/j.ajem.2015.04.065
M.A. Hieger, DO ⁎ 
, S.R. Rose, PharmD, K.L. Cumpston, DO, P.E. Stromberg, MD
, S.R. Rose, PharmD, K.L. Cumpston, DO, P.E. Stromberg, MD Division of Clinical Toxicology, Department of Emergency Medicine, VCU Medical Center, Richmond, VA
Virginia Poison Center, Richmond, VA
Department of Emergency Medicine, VCU Medical Center, Richmond, VA
⁎Corresponding author. Division of Clinical Toxicology, Department of Emergency Medicine, VCU Medical Center, Virginia Poison Center, Richmond, VA.
B.K. Wills, DO
Division of Clinical Toxicology, Department of Emergency Medicine, VCU Medical Center, Richmond, VA
Virginia Poison Center, Richmond, VA
Department of Emergency Medicine, VCU Medical Center, Richmond, VA
| ☆ | An abstract of this data was presented at the North American Congress of Clinical Toxicology annual meeting held in Las Vegas, NV, 2012. |
© 2015
Elsevier Inc. Tous droits réservés.
Vol 33 - N° 12
P. 1843.e1-1843.e3 - décembre 2015 Retour au numéro
Article précédent
- Acute neurocysticercosis presenting as suicidal ideation
- James F. Martin, Jessica Vidas, Ali Baday
- Ranolazine overdose–induced seizures
- Nour Akil, Edward Bottei, Sameer Kamath
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?